We are live on
!
Find out more
MoonLake Immunotherapeutics
MLTX
MLTX
15.01
USD
-0.18
1.18%
At close
Updated
Sep 4, 4:00 PM EDT
Pre-market
After hours
15.04
+0.03
0.2%
1 day
-1.18%
5 days
0.47%
1 month
-16.29%
3 months
-19.82%
6 months
-17.25%
Year to date
25.61%
1 year
-74.87%
5 years
51.62%
10 years
43.09%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 51 |
BCLSI
51
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| – | -$2.49M | -250,000 | Closed |
|
| 52 |
FCMV
52
Foresite Capital Management V
Larkspur,
California
| – | -$2.49M | -250,000 | Closed |
|
| 53 |
RSCM
53
Rock Springs Capital Management
Baltimore,
Maryland
| – | -$1.54M | -154,500 | Closed |
|
| 54 |
CAC
54
Cowen and Company
New York
| – | -$622K | -62,475 | Closed |
|
| 55 |
GCL
55
Glazer Capital LLC
New York
| – | -$577K | -58,541 | Closed |
|
| 56 |
EAM
56
Exos Asset Management
New York
| – | -$250K | -25,100 | Closed |
|
| 57 |
57
Janus Henderson Group
London,
| – | -$150K | -15,168 | Closed |
|